[Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood]

I Contardi1

  • 1Divisione di Pediatria, Ospedale Civico di Codogno, MI.

La Clinica Terapeutica
|March 31, 1991
PubMed

Insights

This study found that probiotics, specifically lactobacilli, can prevent diarrhea in infants treated with amoxycillin. Probiotic use led to fewer bowel disturbances compared to amoxycillin alone.

Area of Science:

  • Pediatric medicine
  • Microbiology
  • Gastroenterology

Background:

  • Amoxycillin is a common antibiotic in pediatric care.
  • Antibiotic use, including amoxycillin, can disrupt the infant gut microbiome.
  • This disruption may lead to gastrointestinal issues like diarrhea.

Purpose of the Study:

  • To investigate the efficacy of probiotic lactobacilli in preventing amoxycillin-induced diarrhea in infants.
  • To assess the impact of oral bacterial therapy on bowel function during antibiotic treatment.

Main Methods:

  • A controlled, randomized clinical trial involving 40 infants receiving oral amoxycillin.
  • Infants were divided into two groups: one receiving amoxycillin plus lactobacilli, the other amoxycillin alone.
  • Fermented milk products containing lactobacilli were used for the probiotic intervention.

Main Results:

  • Infants receiving amoxycillin plus lactobacilli (Group 1) experienced fewer stool passages and more formed stools.
  • Infants receiving only amoxycillin (Group 2) showed an increased frequency of gastrointestinal disorders.
  • Lactobacilli supplementation demonstrated a protective effect against antibiotic-associated diarrhea.

Conclusions:

  • Oral bacterial therapy with lactobacilli is effective in preventing diarrhea in infants treated with amoxycillin.
  • Probiotic supplementation can help maintain gut health during antibiotic therapy in pediatric patients.
  • Lactobacilli represent a viable strategy to mitigate common side effects of amoxycillin in infancy.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...